Cargando…

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model

Large cell lung carcinoma (LCLC) is one form of NSCLC that spreads more aggressively than some other forms, and it represents an unmet medical need. Here, we investigated for the first time the effect of the anti-CK2 CIGB-300 peptide in NCI-H460 cells as an LCLC model. NCI-H460 cells were highly sen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez, George V., Rosales, Mauro, Ramón, Ailyn C., Rodríguez-Ulloa, Arielis, Besada, Vladimir, González, Luis J., Aguilar, Daylen, Vázquez-Blomquist, Dania, Falcón, Viviana, Caballero, Evelin, Carvalho, Paulo C., Caldeira, Rodrigo Soares, Yang, Ke, Perera, Yasser, Perea, Silvio E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856093/ https://www.ncbi.nlm.nih.gov/pubmed/36672551 http://dx.doi.org/10.3390/biomedicines11010043

Ejemplares similares

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
por: Rosales, Mauro, et al.
Publicado: (2021)

CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition
por: Rosales, Mauro, et al.
Publicado: (2022)

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
por: Ramón, Ailyn C., et al.
Publicado: (2022)

Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines
por: Vázquez-Blomquist, Dania, et al.
Publicado: (2023)

CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells
por: Ramón, Ailyn C., et al.
Publicado: (2022)

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
por: Gottardo, Maria F., et al.
Publicado: (2020)

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specifc cell-permeable peptide inhibitor
por: Martins, Leila R., et al.
Publicado: (2013)

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945
por: Rosales, Mauro, et al.
Publicado: (2021)

Proteomic Study to Survey the CIGB-552 Antitumor Effect
por: Rodríguez-Ulloa, Arielis, et al.
Publicado: (2015)

Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer
por: Sarduy, M R, et al.
Publicado: (2015)

The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines
por: Cirigliano, Stéfano M., et al.
Publicado: (2017)

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support
por: Perera, Yasser, et al.
Publicado: (2020)

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015)

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
por: Cruz, Leticia R., et al.
Publicado: (2020)

Predicting CK2 beta-dependent substrates using linear patterns
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells
por: Fernández Massó, Julio R., et al.
Publicado: (2013)

The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
por: Daghero, Hellen, et al.
Publicado: (2020)

In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface
por: Bestgen, Benoît, et al.
Publicado: (2017)

Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity
por: Astrada, Soledad, et al.
Publicado: (2018)

CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients
por: Hernandez-Cedeño, M., et al.
Publicado: (2021)

HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF INNATE AND ADAPTIVE IMMUNITY FOR NASAL VACCINES CIGB 2020 AND MAMBISA AGAINST COVID-19
por: Guillen, G., et al.
Publicado: (2023)

Role of Plant-Specific N-Terminal Domain of Maize CK2β1 Subunit in CK2β Functions and Holoenzyme Regulation
por: Riera, Marta, et al.
Publicado: (2011)

Overexpression of Nuclear Protein Kinase CK2 α Catalytic Subunit (CK2α) as a Poor Prognosticator in Human Colorectal Cancer
por: Lin, Kai-Yuan, et al.
Publicado: (2011)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Protein kinase CK2α subunits constitutively activate ABA signaling in Arabidopsis
por: Nagatoshi, Yukari, et al.
Publicado: (2018)

Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach
por: Miranda, Jamilet, et al.
Publicado: (2021)

Anti-Inflammatory Activity of CIGB-258 against Acute Toxicity of Carboxymethyllysine in Paralyzed Zebrafish via Enhancement of High-Density Lipoproteins Stability and Functionality
por: Cho, Kyung-Hyun, et al.
Publicado: (2022)

The regulatory subunits of CK2 complex mediate DNA damage response and virulence in Candida Glabrata
por: Ni, Qi, et al.
Publicado: (2023)

Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects
por: Berlanga-Acosta, Jorge, et al.
Publicado: (2017)

Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α′
por: Hochscherf, Jennifer, et al.
Publicado: (2017)

CIGB-258 Exerts Potent Anti-Inflammatory Activity against Carboxymethyllysine-Induced Acute Inflammation in Hyperlipidemic Zebrafish via the Protection of Apolipoprotein A-I
por: Cho, Kyung-Hyun, et al.
Publicado: (2023)

More precise prediction in Chinese patients with penile squamous cell carcinoma: protein kinase CK2α catalytic subunit (CK2α) as a poor prognosticator
por: Li, Zai-Shang, et al.
Publicado: (2017)

Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit
por: Baier, Andrea, et al.
Publicado: (2017)

Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells
por: Alcaraz, Estefania, et al.
Publicado: (2020)

Utility of CK8, CK10, CK13, and CK17 in Differential Diagnostics of Benign Lesions, Laryngeal Dysplasia, and Laryngeal Squamous Cell Carcinoma
por: Boricic, Novica, et al.
Publicado: (2022)

An Immunohistochemical Expression of CK5/6, CK7, and CK20 on Cell Blocks in Metastatic Cervical Lymphadenopathy
por: Kaur, Amanpreet, et al.
Publicado: (2022)

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial
por: Solares, Ana M., et al.
Publicado: (2011)

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
por: Khilko, Natalya, et al.
Publicado: (2010)

Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma
por: Rabjerg, Maj, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8to0jahh6a7d7bhqlg9hv8mpo9